Carotid Revascularization: Selection Criteria and Medical Management
For symptomatic carotid stenosis ≥70%, carotid endarterectomy (CEA) should be performed urgently—ideally within 2-14 days of the ischemic event—as it provides superior stroke prevention compared to medical therapy alone, with CEA preferred over carotid artery stenting (CAS) in most patients, particularly those over age 70. 1
Symptomatic Carotid Stenosis (Recent TIA or Non-Disabling Stroke)
Degree of Stenosis and Intervention Choice
70-99% Stenosis:
- CEA is the first-line intervention 1, 2
- Must be performed by a surgeon/center with documented perioperative stroke/death rates <6% 1
- Timing is critical: perform within first few days if clinically stable, or within 14 days if not initially stable 1
50-69% Stenosis:
- CEA is reasonable but benefit is substantially lower than with ≥70% stenosis 2, 3
- Important caveat: Women with 50-69% stenosis showed no clear benefit in NASCET trial 2
- Requires life expectancy >5 years to derive benefit, as CEA carries higher risk in first 2 years but shows benefit at 5 years 2
CEA vs. CAS: Age-Based Algorithm
Age ≥70 years:
- Choose CEA over CAS due to higher peri-procedural stroke/death risk with stenting in older patients 1
Age <70 years:
CAS is reserved for patients who are NOT surgical candidates:
- Technical reasons: stenosis above C2 vertebra, intrathoracic location 1
- Anatomic reasons: hostile neck, post-radiation stenosis, previous CEA with restenosis, contralateral vocal cord paralysis 1, 3
- Medical reasons: severe cardiac/pulmonary comorbidities 1
When CAS is performed, the interventionist must demonstrate perioperative stroke/death rates <5% 1
Asymptomatic Carotid Stenosis
Intervention Criteria
60-99% Stenosis:
- CEA may be considered in carefully selected patients 1
- Critical requirements:
Important context: Recent CREST-2 data (2025) showed that adding CAS to optimal medical therapy provided modest benefit (2.8% vs 6.0% 4-year stroke rate, NNT=31), while CEA added to optimal medical therapy did not reach statistical significance 5. This represents a paradigm shift emphasizing that aggressive medical management is now the cornerstone for asymptomatic disease, with revascularization reserved for highly selected patients 6, 5.
When NOT to Intervene
- Stenosis <60% 1
- Life expectancy <5 years 1
- Chronic total occlusion 3, 7
- Severe disability (Modified Rankin Scale ≥3) precluding functional benefit 3, 7
Mandatory Medical Therapy (All Patients)
Regardless of whether revascularization is performed, ALL patients with carotid stenosis require aggressive medical management: 1, 2
Antiplatelet Therapy
- Aspirin 75-325 mg daily (most commonly 81-325 mg)
- Clopidogrel 75 mg daily
- Cilostazol 200 mg daily (particularly in Asian populations)
Dual antiplatelet therapy (DAPT): Generally NOT recommended long-term due to increased bleeding without clear stroke benefit 4
- Exception: Patients with stenosis/occlusion of major arteries or ≥2 vascular risk factors may benefit from DAPT including cilostazol 4
Lipid Management
Blood Pressure Control
Additional Risk Factor Management
Intracranial Stenosis: Critical Distinction
Intracranial stenting is NOT recommended for recently symptomatic 70-99% intracranial stenosis 1
Medical management for intracranial disease:
- Dual antiplatelet therapy: ASA 325 mg + Clopidogrel 75 mg for up to 90 days (started within 30 days of event) 1
- Aggressive vascular risk factor management 1
- Intracranial angioplasty may be considered only in carefully selected patients who fail maximal medical therapy 1
Common Pitfalls to Avoid
Delaying intervention in symptomatic patients: The benefit of CEA diminishes significantly after 14 days; early intervention (within 2-14 days) is crucial 1, 2
Using CAS in elderly patients (≥70 years): This population has consistently shown worse outcomes with stenting versus surgery 1
Performing revascularization without documented low complication rates: Surgical/interventional teams must audit and demonstrate acceptable perioperative outcomes (<6% for symptomatic, <3% for asymptomatic) 1
Intervening on asymptomatic stenosis without considering life expectancy: Patients need >5 years to derive benefit from prophylactic intervention 1, 2
Neglecting medical therapy: Even with revascularization, aggressive medical management remains essential and is the primary driver of stroke risk reduction in the modern era 1, 2, 5